BioSpace News Archive

Company Ramps Up Commercialization of ControlRad Trace, an FDA-cleared Technology to Reduce Radiation Exposure During Fluoroscopically Guided Procedures

RAPID expands worldwide reach to bring Vietnam the only clinically validated, next-generation imaging platform for assessing stroke

These shares represent approximately 0.77% of the Company’s issued and outstanding ordinary shares as of December 16, 2019.

Company closes $5.6 million in funding and secures distinguished board of directors as it seeks to empower individual health ownership with personalized biological analysis and storage

This unique grant program allows investigators who can make a significant impact to pursue transformative research.

The gross proceeds from the offering will be approximately $10 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by ContraFect.

Armstrong to drive Leading Edge’s cannabinoid-based businesses

First Tranche of $2.0 Million Total Offering; Proceeds to Further Develop Core Product

FemmePharma today announced it has received clearance from the US Food & Drug Administration under Section 510(k) of the Food, Drug and Cosmetic Act to manufacture and bring to market its SatisfaiteTM delivery system for the relief of vaginal symptoms of menopause affecting more than one in three women in the US alone.

PENTAX Medical, a healthcare industry leader in diagnostic and therapeutic endoscopy, has announced the launch of the EB19-J10U Ultrasound Video Bronchoscope.